Literature DB >> 11756573

Novel hepatocyte growth factor/scatter factor isoform transcripts in the macaque endometrium and placenta.

J Suzanne Lindsey1, Robert M Brenner.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) induces proliferation, motility and morphogenesis of cells that express the proto-oncogene for the tyrosine kinase receptor, c-Met. Because these cellular events occur in the endometrium during the menstrual cycle and in placenta during development, we have initiated studies of this growth factor in these tissues from macaques. Several HGF/SF alternatively spliced transcripts have been previously reported in other tissues. However, expression of HGF/SF isoforms in the endometrium has not been studied. Here we describe the relative transcript amounts of HGF/SF isoforms in the endometrium and placenta using RNase protection analyses. During these analyses, we discovered two unexpected protected bands that were found through sequence analyses to represent isoforms similar to the previously reported NK1 and NK2 except that they encode a five amino acid deletion in the first kringle domain. We designated these two isoforms as dNK1 and dNK2. Endometrium expressed all of the isoforms; however, dNK2 was consistently expressed at higher levels than NK2 transcripts. In contrast, placenta expressed NK2 and dNK2 mRNA at equal levels, and both NK1 and dNK1 were undetectable in placenta. HGF/SF function in endometrium and placenta may involve complex interactions between the isoforms of HGF/SF and those of c-Met.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756573     DOI: 10.1093/molehr/8.1.81

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  3 in total

1.  Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.

Authors:  Xuan Zhang
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

2.  High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients.

Authors:  Israel Cañadas; Alvaro Taus; Iria González; Xavier Villanueva; Javier Gimeno; Lara Pijuan; Manuel Dómine; Albert Sánchez-Font; Ivan Vollmer; Silvia Menéndez; Oriol Arpí; Sergi Mojal; Federico Rojo; Ana Rovira; Joan Albanell; Edurne Arriola
Journal:  Oncotarget       Date:  2014-07-30

Review 3.  Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.

Authors:  Ognoon Mungunsukh; Elizabeth A McCart; Regina M Day
Journal:  Biomedicines       Date:  2014-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.